A couple years ago, scientists discovered a curious little tree with curious little fruit in the great Down Under they thought might contain the cure for certain types of cancer. It turns out they may have been right. EBC-46, a drug derived from the rainforest blushwood tree, was used to treat eight cancer patients. The results were astonishing, and the Brisbane-based researchers responsible for the new drug hope to propel a commercial version to market in just four years.

Of course, if we continue eradicating rainforests at the current rate, four years might be too little too late. Believe it or not, an enormous percentage of all medicines are derived from plants–and we’ve only studied the medicinal characteristics of less than 10% of the world’s plants. Kind of puts humanity’s idiocy into perspective, doesn’t it? It might be extremely easy to cure cancer or other diseases and ailments, but we’ll never even know.

So far, patients have been treated for melanoma, breast adenocarcinoma, squamous cell carcinoma, and basal cell carcinoma. No one experienced any ill effect from the miracle drug, and most tumors were eradicated within a week of treatment.

Are you that guy who would drag a dog from a burning vehicle, and then go back to help the pair of whining twins in the backseat? Well, you’ll be pleased to know that the results of the new cancer drug appear to work the same regardless of species. A new study will be conducted on at least 120 cancer cases affecting man’s best friend. If the results show promise, it should allow the research team to move into international veterinary markets with the magical EBC-46.

When a cancer cure is found, our biggest threat is heart disease. If both ailments are eliminated from most of the human population, our lifespan would increase upwards of a decade. Pretty cool, huh?


About Author

Jeff is a self-proclaimed pragmatic futurist; that is, he has high hopes for absurd life-altering technologies which sound too good to be true, and probably are. Although he writes on a variety of subjects, his real passion is for technological innovation and the people who make it happen. By day, he enjoys fuzzy bunnies, kittens, puppies, roller coasters and a sardonic written word or two. By night, he's busy running MMR, replaying a random Final Fantasy game, or pretending to be Batman. He currently resides in Upstate NY.